World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 16 December 2017
Main ID:  NCT02909244
Date of registration: 05/09/2016
Prospective Registration: No
Primary sponsor: Imagine Institute
Public title: Study of Gut Microbiota in Primary Immune Deficiency, Possibly Associated With Inflammatory Bowel Disease DIPobiota
Scientific title: Study of Gut Microbiota in Primary Immune Deficiencies, Possibly Associated With Inflammatory Bowel Disease (Chronic Granulomatous Disease, XIAP Gene Deficiency, or TTC7A Gene Deficiency)
Date of first enrolment: February 2015
Target sample size: 51
Recruitment status: Completed
URL:  https://clinicaltrials.gov/show/NCT02909244
Study type:  Observational
Study design:   
Phase:  N/A
Countries of recruitment
France
Contacts
Name:     Sylvain Latour
Address: 
Telephone:
Email:
Affiliation:  Imagine Institute
Name:     Alain Fischer
Address: 
Telephone:
Email:
Affiliation:  Imagine Institute
Name:     Harry Sokol
Address: 
Telephone:
Email:
Affiliation:  Saint-Antoine Hospital
Name:     Olivier Join-Lambert
Address: 
Telephone:
Email:
Affiliation:  Necker - Enfants malades Hospital
Key inclusion & exclusion criteria

Inclusion Criteria (Patients with one of the 3 specific PID mentioned above):

- Presenting a Primary Immune Deficiency (CGD, XIAP ou TTC7A deficiency) with or without
inflammatory digestive disease

Inclusion Criteria (Control patients without one of the 3 specific PID mentioned above):

- No antibiotic treatment in the month preceding the inclusion

Exclusion Criteria (all patients):

- Patients having a received a gene therapy or a Hematopoietic stem cell transplantation



Age minimum: N/A
Age maximum: N/A
Gender: All
Health Condition(s) or Problem(s) studied
Primary Immune Deficiencies
Intervention(s)
Biological: Biological sampling
Primary Outcome(s)
Number of factors associated with the onset of an inflammatory colitis in patients with three Primary Immuno-Deficiencies, identified in the study population [Time Frame: 3 years and 8 months]
Secondary Outcome(s)
Secondary ID(s)
IMIS2014-02
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Assistance Publique - Hôpitaux de Paris
Saint Antoine University Hospital
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history